7 completed. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow bixalomer: new trials by email Literature Review of bixalomer trials Research Report on bixalomer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease Bixalomer - Chronic Kidney Disease | Completed | Astellas Pharma Inc | 144 | 2016-06-01 | 2024-10-16 | |
| A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules ASP1585 - Healthy, Urine Phosphorus Excretion | Phase 1 | Completed | Astellas Pharma Inc | 60 | 2014-08-01 | 2015-08-24 |
| Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis bixalomer - Chronic Renal Failure | Completed | Astellas Pharma Inc | 123 | 2013-03-19 | 2024-10-22 | |
| Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis ASP1585 - Chronic Kidney Disease, Renal Insufficiency | Phase 3 | Completed | Astellas Pharma Inc | 105 | 2013-03-01 | 2015-06-09 |
| Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients Kiklin capsules - Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis | Completed | Astellas Pharma Inc | 1078 | 2013-01-01 | 2017-01-27 | |
| A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis ASP1585, placebo - Chronic Kidney Disease, Renal Insufficiency | Phase 3 | Completed | Astellas Pharma Inc | 163 | 2012-10-01 | 2014-07-16 |
| Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia ASP1585 - Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia | Phase 2 | Completed | Astellas Pharma Inc | 73 | 2008-01-01 | 2016-06-21 |
Renal Insufficiency, Chronic (5) · Hyperphosphatemia (3) · Renal Insufficiency (2) · Kidney Failure, Chronic (1)
Japan (7)